Rady A. Johnson
Executive Vice President, Pfizer.
Companies
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 23, 2024Shares withheld for tax 23,788 shares at $27.37 of Pfizer2
- Feb 23, 2024Shares withheld for tax 2,132 shares at $27.76 of Pfizer2
- Feb 23, 2024Exercised options 29,436 shares at $27.34 of Pfizer2
- Feb 25, 2023Shares withheld for tax 14,966 shares at $43.44 of Pfizer3
- Feb 25, 2023Shares withheld for tax 7,870 shares at $41.75 of Pfizer3
- Feb 25, 2023Exercised options 33,654 shares at $22.89 of Pfizer3
- Feb 22, 2023Shares withheld for tax 19,211 shares at $43.70 of Pfizer4
- Feb 22, 2023Shares withheld for tax 4,526 shares at $42.38 of Pfizer4
- Feb 22, 2023Exercised options 31,558 shares at $30.17 of Pfizer4
- Feb 26, 2022Shares withheld for tax 13,688 shares at $50.64 of Pfizer5
- Feb 26, 2022Shares withheld for tax 7,511 shares at $47.72 of Pfizer5
- Feb 26, 2022Exercised options 29,317 shares at $25.60 of Pfizer5
- Feb 23, 2022Shares withheld for tax 17,550 shares at $51.28 of Pfizer6
- Feb 23, 2022Shares withheld for tax 6,871 shares at $46.87 of Pfizer6
- Feb 23, 2022Exercised options 35,457 shares at $27.34 of Pfizer6
- Dec 3, 2021Sold 4,727 shares at $53.39 of Pfizer7
- Dec 3, 2021Sold 3,627 shares at $53.38 of Pfizer7
- Dec 3, 2021Sold 2,756 shares at $53.40 of Pfizer7
- Dec 3, 2021Sold 2,719 shares at $53.50 of Pfizer7
- Dec 3, 2021Sold 2,200 shares at $53.46 of Pfizer7
- Dec 3, 2021Sold 1,200 shares at $53.49 of Pfizer7
- Dec 3, 2021Sold 500 shares at $53.42 of Pfizer7
- Dec 3, 2021Sold 400 shares at $53.41 of Pfizer7
- Dec 3, 2021Sold 371 shares at $53.37 of Pfizer7
- Dec 3, 2021Sold 300 shares at $53.51 of Pfizer7
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Dec 3, 2021 | PFE | Sale | $1.0M | −45.8% | +116.0% | −5.3% |
| Apr 29, 2020 | PFE | Sale | $503.5K | −18.6% | +181.8% | +36.5% |
| Mar 15, 2019 | PFE | Sale | $357.8K | −25.7% | +200.1% | +13.0% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARPfizer, Executive Vice President
- 2
- 3SEC EDGARForm 4 filed Feb 28, 2023
- 4SEC EDGARForm 4 filed Feb 24, 2023
- 5SEC EDGARForm 4 filed Mar 1, 2022
- 6SEC EDGARForm 4 filed Feb 25, 2022
- 7SEC EDGARForm 4 filed Dec 6, 2021